Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies for ...
Common Stock Will Begin Trading on Split-Adjusted Basis on February 6, 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results